Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 11, Issue Suppl 2
629-B Window of opportunity for durvalumab plus metformin trial in head & neck squamous cell carcinoma (HNSCC)
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular Abstracts – Part 2
Clinical Trial Completed
629-B Window of opportunity for durvalumab plus metformin trial in head & neck squamous cell carcinoma (HNSCC)
Online download statistics by month:
Online download statistics by month: October 2023 to June 2025
Abstract
Full
Pdf
Oct 2023
4
0
0
Nov 2023
144
0
9
Dec 2023
51
0
4
Jan 2024
36
0
0
Feb 2024
26
0
4
Mar 2024
18
0
2
Apr 2024
26
0
2
May 2024
18
0
0
Jun 2024
36
0
2
Jul 2024
26
0
1
Aug 2024
32
0
4
Sep 2024
48
0
4
Oct 2024
38
0
4
Nov 2024
26
0
5
Dec 2024
28
0
3
Jan 2025
22
0
4
Feb 2025
8
0
3
Apr 2025
0
0
1
May 2025
0
0
9
Jun 2025
0
0
2
Total
587
0
63
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF